New York, Aug. 25, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the publication of the report “Automated Cell Counters Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Type and End User” – https://www.reportlinker .com/p06316357/?utm_source=GNW
The growth of the market is attributed to the high prevalence of infectious and chronic diseases.
Additionally, advancements in automated cell counters are expected to become a significant trend in the market over the forecast period. However, lack of skilled labor and high cost of instruments are limiting the market growth.
Chronic diseases are conditions that are present in an individual for one or more years, requiring ongoing medical care and may also result in limited daily activities. Chronic diseases are currently the leading cause of death among adults in several countries.
According to the World Health Organization (WHO), 41 million people die each year from chronic diseases, which is equivalent to 71% of all deaths worldwide. According to the Centers for Disease Control and Prevention (CDC), six out of ten adults in the United States have one chronic condition and four out of ten adults have two or more chronic conditions.
According to Cancer Research UK, around 17 million new cases of cancer were detected worldwide in 2018. Additionally, in 2018 around 9.6 million deaths occurred due to cancer globally.
Infectious diseases are caused by infectious agents, such as viruses, bacteria, parasites, fungi and toxic products. HIV is a major public health problem worldwide.
According to the Joint United Nations Program on HIV/AIDS (UNAIDS), an estimated 37.7 million people had HIV in 2020; of these, 1.7 million were children aged 0-14 and 36 million were adults. In addition, more than half of them (53%) were girls and women, and 1.5 million new cases of HIV were reported globally in 2020. Similarly, hepatitis is an inflammation liver caused by a viral infection. The five main strains of hepatitis virus are A, B, C, D and E. According to the WHO, about 58 million people suffer from chronic hepatitis C and about 1.5 million new infections occur each year.
According to the WHO, tuberculosis (TB) is the thirteenth leading cause of death worldwide and the second infectious disease after COVID-19. In addition, 1.5 million deaths were caused by tuberculosis in 2020 (including 214,000 people affected by HIV). In 2020, the WHO estimated that 10 million people were affected by tuberculosis, including 1.1 million children, 3.3 million women and 5.6 million men. Tuberculosis cases are present in all age groups and in all countries. In addition, 30 high TB burden countries accounted for 86% of new TB cases in 2020. Eight countries recorded two-thirds of the total TB cases, with India leading, followed by China, Philippines , Indonesia, Nigeria, Pakistan, Bangladesh and South Africa.
Diagnoses are essential in determining the direction of any medical treatment of infectious and chronic diseases. Cell counting is one of the methods used for the detection of these diseases.
Hence, the rising prevalence of infectious and chronic diseases across the globe is driving the growth of the automated cell counter market.
On the other hand, lack of skilled labor and high cost of instruments is hampering the overall growth of the automated cell counter market.
The ongoing pharmaceutical and biotechnology research and development of various drugs to treat diseases such as cancer, cardiovascular disorders, HIV/AIDS, etc. With the technological advancements in automated cell counters and an increase in the application areas of the instrument, there has been a change in the use of automated cell counters.
The operation of the automated cell counter is difficult, and knowledge of this instrument is very important; therefore, there is a demand for skilled labor. Preparing a sample for such instruments is tedious work, and the consumables needed during the procedure must also be handled properly.
Thus, the lack of skilled manpower who can easily operate these instruments is hampering the growth of the automated cell counter market.
The price of automated cell counter ranges from 3000 to 6000 US dollars, and the price of associated accessories such as pipettes, consumables and plates also increases the total cost of the instrument. The requirement of skilled workers is necessary because handling the sample is extremely difficult and there are risks of improper sample handling, which also increases the overall cost of the instrument.
The cost of a single piece of equipment is high. Additionally, instrument damage and instrument maintenance also increase the overall cost of the automated cell counter.
The implementation of automated cell counters requires high capital which limits the growth of the automated cell counters market.
Based on type, the automated cell counter market is segmented into hematocytometers, flow cytometers, electrical impedance coulter counters and spectrophotometers. In 2021, the spectrophotometer segment held the largest market share.
However, the hemocytometer segment is expected to register the highest CAGR from 2022 to 2028. On the basis of end-user, the market is segmented into hospitals, research laboratories, diagnostic centers and others.
The hospital segment held the largest market share in 2021. However, the research laboratory segment is expected to register the highest CAGR during the forecast period.
Various organic and inorganic strategies are adopted by companies in the Automated Cell Counters market. Organic strategies primarily include product launches and product endorsements.
Further, the inorganic growth strategies seen in the market are acquisitions, collaborations, and partnerships. These growth strategies enable market players to expand their businesses and improve their geographical presence, thereby contributing to the overall growth of the market.
Moreover, acquisition and partnership strategies help market players to strengthen their customer base and expand their product portfolios. Some of the prominent developments by the major players in the Automated Cell Counters market are listed below.
• In April 2021, Eppendorf announced the launch of a new product, “Centrifuge 5910 Ri”, designed to increase efficiency in the laboratory. This new centrifuge succeeds the popular Centrifuge 5910 R and is a flagship product in Eppendorf’s versatile centrifuge line that offers scientists advanced features to simplify and speed up centrifugation steps.
Centers for Disease Control and Prevention (CDC), Infectious Disease Research Institute (IDRI), Saudi Society for Blood Disorders (SSBD), Saudi Commission for Health Specialties (SCFHS), National Institute of Allergy and Infectious Disease (NIAID), Australian Federation of AIDS Service Organizations (AFAO) are some of the major primary as well as secondary sources that are referenced during the preparation of the Automated Cell Counters market report.
Read the full report: https://www.reportlinker.com/p06316357/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.